Compounds > tranylcypromine
Page last updated: 2024-08-22

tranylcypromine and Neuroleptic Malignant Syndrome

tranylcypromine has been researched along with Neuroleptic Malignant Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alampi, D; Capelli, O; Castagna, A; Di Placido, G; Lappa, A; Podestà, M; Semeraro, F1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T1

Other Studies

2 other study(ies) available for tranylcypromine and Neuroleptic Malignant Syndrome

ArticleYear
Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Intensive care medicine, 2002, Volume: 28, Issue:7

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Dantrolene; Disseminated Intravascular Coagulation; Female; Fluid Therapy; Humans; Infusions, Intravenous; Italy; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Tranylcypromine; Treatment Outcome; Trifluoperazine

2002
Neuroleptic malignant syndrome without neuroleptics.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan

1990